Notice2022-13418
National Cancer Institute; Notice of Charter Renewal
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 23, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 120 (Thursday, June 23, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 120 (Thursday, June 23, 2022)]
[Notices]
[Page 37521]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-13418]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Clinical Trials and
Translational Research Advisory Committee, was renewed for an
additional two-year period on April 14, 2022.
It is determined that the National Cancer Institute Clinical Trials
and Translational Research Advisory Committee, is in the public
interest in connection with the performance of duties imposed on the
National Cancer Institute by law, and that these duties can best be
performed through the advice and counsel of this group.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
<a href="/cdn-cgi/l/email-protection#036b6271716a70606f436e626a6f2d6d6a6b2d646c75"><span class="__cf_email__" data-cfemail="aec6cfdcdcc7ddcdc2eec3cfc7c280c0c7c680c9c1d8">[email protected]</span></a>.
Dated: June 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13418 Filed 6-22-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 23, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.